RDD 2022

Focus on Therapeutics

Focus on Therapeutics: New Tools, Therapies & Technologies

Monday • May 2, 2022 • 10:30–12:00 Noon EDT • National Ballroom
Moderator: Peter R. Byron

Physiologically Relevant Microfluidic Platforms for High Throughput Preclinical Development

Hui Xin Ong
Macquarie University & Woolcock Institute

Pivoting Research to Fight COVID-19: Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing

Robert Williams III
The University of Texas at Austin

Adoption and Implementation of Respiratory Digital Health Solutions Post-Pandemic

Mayur Patel
PA Consulting

Discover More

Developing Biologics For Respiratory Delivery – Real World Lessons And Examples

Mark Parry and Ashleigh Wake
Intertek

RB

Pathophysiological Changes in a Clinically Relevant Large Animal Model of Experimental Chronic Obstructive Pulmonary Disease (COPD)

Rob Bischof
Federation University

GINA 2021 Guidelines and Considerations of Products Currently Available and Opportunities for Novel Combination Inhalers to Meet the Future Needs of Patients

Helen Derbyshire
Kindeva Drug Delivery

Niclosamide Dry Powder for Inhalation Prepared by Thin Film Freezing Technology is Effective Against the COVID-19 Infection in the Golden Syrian Hamster Model

Miguel Orlando Jara Gonzalez
The University of Texas at Austin

Influence of Gender on the Disposition of OHet72 after Pulmonary Administration

Margaret Bourlon
University of Oklahoma

Formulation and Characterization of a Dry Powder Inhaler Containing an ACE2 Miniprotein for SARS-CoV-2 Infection Inhibition

Stefania Glieca and Francesca Buttini
University of Parma

Implications of Ryegrass Pollen Exposure on Respiratory Cell Inflammatory Expression and Cellular Viscoelastic Properties

Aylin Cidem
Woolcock Institute of Medical Research

CONFERENCE SUPPORTERS

WORKSHOP PRESENTERS

EXHIBITORS

↑ Back to Top